Skip to content

Study · Not a test of the peptide alone · 2023

1 result

Xuanfei Baidu Decoction suppresses complement overactivation and ameliorates IgG immune complex-induced acute lung injury by inhibiting JAK2/STAT3/SOCS3 and NF-κB signaling pathway.

Li C, Li Y, Zhang H, Zhuo Y, Zhang L, Yang L, Gao Q, Tu Z, Shao R, Wang Y, Zhang J, Cui L, Zhang S

Phytomedicine : international journal of phytotherapy and phytopharmacology21 Nov 2022Cited by 18 (Europe PMC)

PMID36610119 (opens in a new tab)PMCIDPMC9678227 (opens in a new tab)DOI10.1016/j.phymed.2022.154551 (opens in a new tab)PepBankPUB-36610119
Source linkPubMedAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone1

In this study, Colivelin was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Colivelin.

  1. 01LabNot a test of Colivelin aloneIn vitro (cells)Mechanism

    In IgG-IC-stimulated macrophages, Colivelin TFA markedly increased inflammatory responses.

    In plain wordsIn cells stimulated with IgG-IC, Colivelin TFA increased inflammatory responses.

    Peptide
    Colivelin
    Outcome
    IncreaseInflammatory responses
    Study

    n: not reported in source

    IgG-IC-stimulated alveolar macrophages
    Outcome group
    Inflammation markers · Immune and inflammation

    Source sentences

    Summary
    Colivelin TFA (CAF, STAT3 activator) and C5a treatment markedly elevated the IgG-IC-triggered inflammatory responses in macrophages
    1 context sentence
    Summary · context
    In vitro, alveolar macrophages inflammation models induced by IgG-IC were performed and treated with different dosage of XFBD-containing serum to investigate the protective role and molecular mechanisms of XFBD.

    In this study, Colivelin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Colivelin.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    27 Oct 2026, 18:20 UTC

    Study results updated

  2. Version 1

    27 Oct 2026, 16:32 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.